A Randomized Trial on Home Telemonitoring for the Management of Metabolic and Cardiovascular Risk in Patients with Type 2 Diabetes

Antonio Nicolucci, Stefania Cercone, Alberto Chiriatti, Fabrizio Muscas, Gianfranco Gensini, Giuseppe Fucito, Antonella Gambini, Eduardo Greca, Rosanna Macrì, Maria Maddalena Matarazzo, Enzo Nunnari, Antonio Oliverio, Marco Petrucci, Angela Piacenti, Biagina Punzo, Giuseppe Ricotta, Maria Cristina Ridolfi, Maria Teresa Santarelli, Maria Grazia Scelsa, Federico SciarraStefania Soldano, Claudia Sperati, Cristina Stirpe, Lucio Tartaglini, Domenico Vagnati, Fabio Valente, Dante Sergio Vittozzi

Research output: Contribution to journalArticlepeer-review

Abstract

Background: This study evaluated whether a home telehealth (HT) system enabling the patient to monitor body weight, blood glucose values, and blood pressure values, associated with remote educational support and feedback to the general practitioner, can improve metabolic control and overall cardiovascular risk in individuals with type 2 diabetes mellitus, compared with usual practice. Materials and Methods: This was a randomized, parallel-group (1:1), open-label, multicenter study conducted in general practice. Follow-up was for 12 months. Results: Overall, 29 general practitioners enrolled 302 patients (153 assigned to the HT group and 149 to the control group). Use of the HT system was associated with a statistically significant reduction in glycated hemoglobin (HbA1c) levels compared with the control group (estimated mean difference, 0.33±0.1; P=0.001). No difference emerged as for body weight, blood pressure, and lipid profile. The proportion of patients reaching the target of HbA1c

Original languageEnglish
Pages (from-to)563-570
Number of pages8
JournalDiabetes Technology and Therapeutics
Volume17
Issue number8
DOIs
Publication statusPublished - Aug 1 2015

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medical Laboratory Technology

Fingerprint

Dive into the research topics of 'A Randomized Trial on Home Telemonitoring for the Management of Metabolic and Cardiovascular Risk in Patients with Type 2 Diabetes'. Together they form a unique fingerprint.

Cite this